蒿甲醚联合Quinimax治疗小儿脑型疟疾33例分析  

Analysis about treatment of children cerebral malaria with artemether unitied Quinimax

作　　者：陈智 欧维琳[2] 

机构地区：[1]桂林市妇女儿童医院,广西桂林541001 [2]桂林医学院,广西桂林541001

出　　处：《四川医学》2009年第7期1097-1098,共2页Sichuan Medical Journal

摘　　要：目的探讨蒿甲醚联合Quinimax治疗小儿脑型疟疾的临床疗效。方法将65例小儿脑型疟疾患儿随机分成治疗组和对照组,治疗组33例给予蒿甲醚联合Quinimax,对照组32例单用Quinimax治疗。结果治疗组退热时间24h,对照组48h,差异有统计学意义(P<0.01);治疗组治愈率93.9%,对照组71.8%,差异有统计学意义(P<0.05);治疗组无1例发生不良反应,对照组不良反应发生率为31.25%;两组病死率和并发症差异无统计学意义。结论蒿甲醚联合Quinimax治疗小儿脑型疟疾退热效果快,治愈率高,不良反应少。Objective To evaluate the therapeutic effect of Artemether unitied Quinimax in 33 children cerebral malaria treatment. Methods 65 children cerebral malaria are divided into 2 random groups, one is treatment group, another is control group. The patients in treatment group is cured by artemether unitied Quinimax, another is cured by Quinimax. Results The antithermic time in treatment group is 24 hours,in control group is 48 hours. Their difference is statistics significance（P〈0. 01 ） ; The cure rate is 93. 9% in treatment group,in control is 71.8%, their difference is statistics significance （P〈0.05）. In treatment group without patient occurred untoward effect,in control group the rate of untoward effect is 31.25%. The difference isn＇t statistics significance of mofiality and complication for 2 groups. Conclusion The antithermic time is fast in treating children cerebral maralia with artemether unitied Quinimax, and the cure rate is better, and untoward effect is lack.

关 键 词：蒿甲醚 QUINIMAX 疟疾 小儿脑型疟疾 

分 类 号：R725.3[医药卫生—儿科]